$20.79 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of Genmab (GMAB)

Market cap: $20.79 Billion

As of December 2023 Genmab has a market cap of $20.79 Billion. This makes Genmab the world's 848th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Genmab from 2010 to 2023

End of year Market Cap

Year Market cap Change
2023$20.79 B-25.62%
2022$27.95 B6.75%
2021$26.18 B-1.86%
2020$26.68 B85.08%
2019$14.41 B43.77%
2018$10.02 B-0.52%
2017$10.08 B0.47%
2016$10.03 B25.41%
2015$8.00 B138.74%
2014$3.35 B65.01%
2013$2.03 B192.75%
2012$0.69 B136.2%
2011$0.29 B-51.56%
2010$0.60 B

End of Day market cap according to different sources

On Dec 10th, 2023 the market cap of Genmab was reported to be:

$21.08 Billion
by Yahoo Finance info icon info icon
$21.08 Billion
by CompaniesMarketCap info icon info icon
$1.50 Billion
by Nasdaq info icon info icon
$21.32 Billion
by Iex Cloud info icon info icon